Static Chart Perspective Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 03:02:20 2026-07-29 pm EDT			5-day change	1st Jan Change
2.915 ^USD	+1.57%		-2.53%	+5.27%

Jul. 28	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
Jul. 17	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

Duration

Period